India’s consumer price inflation is expected to have eased to 4.80% in April, just slightly below March’s rate. Despite the overall moderation in headline inflation, food prices have remained stubbornly high, exerting pressure on household budgets. Food inflation, which makes up nearly half of the consumer price index (CPI) basket, continues to pose a significant
2024
The absence of a Marvel film to kick off the summer movie season for the first time since 2009 has raised concerns within the industry. The lack of a known franchise brand during the highly lucrative summer moviegoing season can have negative repercussions. This year, Universal’s “The Fall Guy” was the headline film for the
The Broadway scene in Spring 2024 saw an influx of new productions, with 18 debuting between mid-March and late April. However, the aftermath of this Broadway crunch is now showing early signs of the inevitable shake-out. One such example is the impending closure of the show Lempicka, with a few others already playing to houses
Berkshire Hathaway saw its Class A shares trade up 1.2% early Monday after the conglomerate posted an impressive 39% year-over-year growth in operating profit. Additionally, the Warren Buffett-led business also reported a significant increase in cash holdings, approaching a record level of $200 billion. Shares of Paramount surged 2.4% following reports that the owner of
The Asian suppliers of Apple Inc, such as Taiwan’s TSMC and Hon Hai Precision Industry, experienced a significant drop in their stock prices amidst concerns over the decline in iPhone sales. The market reacted negatively, with TSMC and Hon Hai Precision Industry recording a 1.5% and 1.9% decrease in their stock prices, respectively. Similarly, AAC
Hotel giant Marriott International (NASDAQ:MAR) has recently increased its annual adjusted profit forecast following a mixed performance in the first quarter. Despite weakening trends in North America, Marriott is relying on the surge in international travel demand to drive its full-year profit. The company anticipates a significant boost in revenue per available room (RevPAR) from
Bond investors are beginning to show a selective interest in adding longer-dated maturities to their portfolios. This shift in strategy is driven by the belief that the Federal Reserve will choose to delay cutting interest rates and reduce them at a slower pace compared to previous easing cycles. The decision to keep rates unchanged at
Australia’s major banks are anticipated to report weaker first-half profits as operating costs remain high and competition for mortgage and deposit sales intensifies. This has led to a reduction in margins, putting a strain on overall profitability. Although historically, rising interest rates have been beneficial for the Big Four banks, the current scenario has forced
Amazon.com recently reported quarterly results that surpassed Wall Street’s expectations. The company’s focus on artificial intelligence has been a significant factor in driving growth in its cloud-computing division. Despite the impressive performance, Amazon’s current-quarter revenue forecast fell short of expectations, causing a slight dip in the stock price during the regular session. Chief Financial Officer
The Federal Trade Commission has taken a bold step in challenging hundreds of alleged “junk” patents held by pharmaceutical companies for 20 brand-name drugs. These companies, including Novo Nordisk, AstraZeneca, Boehringer Ingelheim, and others, have been warned about improperly listed drug patents, particularly for medications related to Type 2 diabetes, asthma, and COPD. The practice
Amazon recently reported its first-quarter earnings, surpassing expectations with both its earnings per share and revenue figures. The company’s revenue of $143.3 billion exceeded the forecasted $142.5 billion, while its earnings per share of 98 cents outperformed the expected 83 cents. The stock market reacted positively to the news, with Amazon’s stock price rising during
Eli Lilly recently announced a significant increase in its annual sales forecast due to explosive demand and increased manufacturing capacity for its weight-loss drug Zepbound. This development has driven the company’s shares to rise nearly 6% in value. The company expects to see substantial production increases in the second half of the year for its
After a prolonged period of dormancy, the Initial Public Offering (IPO) market seems to be making a comeback. Colin Stewart, Morgan Stanley’s global head of technology equity capital markets, expressed optimism about the resurgence of tech companies going public. Stewart predicts that 10 to 15 more tech firms could launch IPOs by the end of
The tech industry has been hit hard by mass layoffs, with over 263,000 job losses recorded in 2023 and more than 75,000 job losses in 2024 so far. Despite blockbuster earnings from companies like Alphabet and Microsoft, the focus has shifted from growth to profitability, leading to a wave of job cuts. Jeff Shulman, a